Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine

被引：25

作者：

Ault, Kevin A. ^{[1
,2
]}

Joura, Elmar A. ^{[3
]}

Kjaer, Susanne K. ^{[4
]}

Iversen, Ole-Erik ^{[5
,6
]}

Wheeler, Cosette M. ^{[7
,8
]}

Perez, Gonzalo ^{[9
]}

Brown, Darron R. ^{[10
]}

Koutsky, Laura A. ^{[11
]}

Garland, Suzanne M. ^{[12
,13
]}

Olsson, Sven-Eric ^{[14
]}

Tang, Grace W. K. ^{[15
]}

Ferris, Daron G. ^{[16
,17
]}

Paavonen, Jorma ^{[18
]}

Steben, Marc ^{[19
]}

Xavier Bosch, F. ^{[20
]}

Majewski, Slawomir ^{[21
]}

Munoz, Nubia ^{[22
]}

Sings, Heather L. ^{[23
]}

Harkins, Kathy ^{[23
]}

Rutkowski, Mary Anne ^{[23
]}

Haupt, Richard M. ^{[23
]}

Garner, Elizabeth I. O. ^{[23
]}

机构：

[1] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30303 USA

[2] Emory Vaccine Ctr, Atlanta, GA USA

[3] Med Univ Vienna, Dept Gynecol & Obstet, Vienna, Austria

[4] Univ Copenhagen, Rigshosp, Danish Canc Soc, Dept Virus Hormones & Canc,Inst Canc Epidemiol, DK-2100 Copenhagen, Denmark

[5] Univ Bergen, Dept Clin Med, Bergen, Norway

[6] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway

[7] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA

[8] Univ New Mexico, Hlth Sci Ctr, Dept Obstet & Gynecol, Albuquerque, NM 87131 USA

[9] Univ Rosario, Bogota, Colombia

[10] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA

[11] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA

[12] Royal Womens Hosp, Dept Microbiol & Infect Dis, Parkville, Vic, Australia

[13] Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic, Australia

[14] Karolinska Inst, Danderyd Hosp, Dept Obstet & Gynaecol, Stockholm, Sweden

[15] Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China

[16] Med Coll Georgia, Dept Family Med, Augusta, GA 30912 USA

[17] Med Coll Georgia, Dept Obstet & Gynecol, Augusta, GA 30912 USA

[18] Univ Cent Hosp, Dept Obstet & Gynecol, Helsinki, Finland

[19] Inst Natl Sante Publ Quebec, Direct Risques Biol & Sante Travail, Quebec City, PQ, Canada

[20] IDIBELL, Inst Catala Oncol, Canc Epidemiol Res Program, Barcelona, Spain

[21] Warsaw Med Univ, Ctr Diagnost & Treatment Sexually Transmitted Dis, Dept Dermatol & Venereol, Warsaw, Poland

[22] Natl Canc Inst, Dept Canc Epidemiol, Bogota, Colombia

[23] Merck & Co Inc, Merck Res Labs, West Point, PA USA

来源：

INTERNATIONAL JOURNAL OF CANCER | 2011年 / 128卷 / 06期

关键词：

adenocarcinoma in situ (AIS); human papillomavirus (HPV); vaccine; natural history; SQUAMOUS-CELL CARCINOMA; GRADE CERVICAL LESIONS; UNITED-STATES; PROPHYLACTIC EFFICACY; INCIDENCE TRENDS; CANCER; WOMEN; HPV; NETHERLANDS; RISK;

D O I：

10.1002/ijc.25723

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The primary objective of this report is to describe the detection of adenocarcinoma in situ (AIS) and associated human papillomavirus (HPV) type distribution that was observed in the context of two phase 3 clinical trials of a quadrivalent HPV6/11/16/18 vaccine. In this intention-to-treat analysis, we include all women who had at least one follow-up visit postenrollment. Healthy women (17,622) aged 15-26 with no history of HPV disease and a lifetime number of less than five sex partners

引用

页码：1344 / 1353

页数：10

共 44 条

[1] Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study
An, HJ
Kim, KR
Kim, IS
Kim, DW
Park, MH
Park, IA
Suh, KS
Seo, EJ
Sung, SH
Sohn, JH
Yoon, HK
Chang, ED
Cho, HI
Han, JY
Hong, SR
Ahn, GH
[J]. MODERN PATHOLOGY, 2005, 18 (04) : 528 - 534
[2] Incidence trends of adenocarcinoma of the cervix in 13 European countries
Bray, F
Carstensen, B
Moller, H
Zappa, M
Zakelj, MP
Lawrence, G
Hakama, M
Weiderpass, E
[J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (09) : 2191 - 2199
[3] Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
Bulk, S
Berkhof, J
Bulkmans, NWJ
Zielinski, GD
Rozendaal, L
van Kemenade, FJ
Snijders, PJF
Meijer, CJLM
[J]. BRITISH JOURNAL OF CANCER, 2006, 94 (01) : 171 - 175
[4] Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women
Bulk, S
Visser, O
Rozendaal, L
Verheijen, RHM
Meijer, CJLM
[J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (06) : 1005 - 1009
[5] Longitudinal evaluation of Interobserver and intraobserver agreement of cervical intraepithelial neoplasia diagnosis among an experienced panel of gynecologic pathologists
Cai, Bing
Ronnett, Brigitte M.
Stoller, Mark
Ferenczy, Alex
Kurman, Robert J.
Sadow, David
Alvarez, Fran
Pearson, Jay
Sings, Heather L.
Barr, Eliav
Liaw, Kai-Li
[J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (12) : 1854 - 1860
[6] Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors:: Implications for screening and prevention
Castellsagué, X
Díaz, M
de Sanjosé, S
Muñoz, N
Herrero, R
Franceschi, S
Peeling, RW
Ashley, R
Smith, JS
Snijders, PJF
Meijer, CJLM
Bosch, FX
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (05): : 303 - 315
[7] Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
Cuzick, Jack
Arbyn, Marc
Sankaranarayanan, Rengaswamy
Tsu, Vivien
Ronco, Guglielmo
Mayrand, Marie-Helene
Dillner, Joakim
Meijer, Chris J. L. M.
[J]. VACCINE, 2008, 26 : K29 - K41
[8] Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix:: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies
de Gonzalez, Amy Berrington
Green, Jane
[J]. INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (04) : 885 - 891
[9] Can we improve the detection of glandular cervical lesions: The role and limitations of the Pap smear diagnosis atypical glandular cells (AGC)
Duska, Linda R.
[J]. GYNECOLOGIC ONCOLOGY, 2009, 114 (03) : 381 - 382
[10] El-Mansi MT, 2006, INT J GYNECOL CANCER, V16, P1025, DOI 10.1111/j.1525-1438.2006.00552.x

← 1 2 3 4 5 →